flu

Positive Vaccine Data Bolster Novavax

The market value of US vaccine maker Novavax is gaining momentum again on the back of promising data the company recently provided on its combined Covid and flu vaccine data.

CureVac Presents Positive Data from mRNA Trials

German biotech CureVac has released preliminary data from its ongoing cooperation with UK drugmaker GSK on a new class of “transformative medicines” based on messenger mRNA.

FDA Approves Genentech Flu Drug

Heavy Flu Season Helps Reckitt Beat Profit Forecasts